Profile data is unavailable for this security.
About the company
Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.
- Revenue in USD (TTM)523.53m
- Net income in USD118.02m
- Incorporated1998
- Employees352.00
- LocationCorcept Therapeutics Inc149 Commonwealth DrMENLO PARK 94025United StatesUSA
- Phone+1 (650) 688-8803
- Fax+1 (650) 327-3218
- Websitehttps://www.corcept.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc | 676.21m | 154.69m | 2.08bn | 1.76k | 14.64 | 3.09 | 10.34 | 3.07 | 2.90 | 2.90 | 12.70 | 13.77 | 0.576 | 2.79 | 5.66 | 383,991.50 | 13.33 | 9.42 | 15.75 | 11.56 | 54.73 | 47.83 | 23.14 | 15.23 | 1.72 | 8.48 | 0.4692 | 0.00 | 29.14 | 16.94 | 50.51 | -- | -4.00 | -- |
| Catalyst Pharmaceuticals Inc | 411.35m | 65.12m | 2.08bn | 167.00 | 32.67 | 3.70 | 20.61 | 5.05 | 0.5384 | 0.5384 | 3.60 | 4.76 | 0.7806 | 3.60 | 8.76 | 2,463,156.00 | 12.36 | 25.42 | 14.19 | 29.81 | 86.74 | 85.63 | 15.83 | 30.87 | 4.83 | -- | 0.00 | 0.00 | 85.90 | 280.39 | -14.05 | -- | 20.21 | -- |
| Endo Inc | 1.92bn | -2.60bn | 2.25bn | 3.00k | -- | -- | -- | 1.18 | -34.02 | -34.04 | 25.08 | -88.41 | -- | -- | -- | -- | -- | -- | -- | -- | 52.36 | -- | -135.65 | -- | 2.75 | 95.17 | 5.83 | -- | -13.25 | -- | 15.87 | -- | -- | -- |
| Amneal Pharmaceuticals Inc | 2.50bn | -168.69m | 2.30bn | 7.70k | -- | -- | 21.57 | 0.9203 | -0.5642 | -0.5642 | 11.52 | -0.2065 | 0.7046 | 2.94 | 4.11 | 324,059.50 | -3.40 | -4.80 | -4.27 | -5.93 | 35.28 | 34.76 | -4.82 | -9.00 | 0.97 | 1.27 | 1.01 | -- | 8.20 | 7.56 | 35.38 | -- | -6.55 | -- |
| Vericel Corp | 207.78m | 451.00k | 2.54bn | 314.00 | 5,472.80 | 10.85 | 470.90 | 12.24 | 0.0096 | 0.0096 | 4.35 | 4.82 | 0.6684 | 4.38 | 4.71 | 661,719.80 | 0.1451 | -3.07 | 0.1621 | -3.50 | 69.50 | 67.87 | 0.2171 | -4.49 | 4.83 | -- | 0.0007 | -- | 20.17 | 16.80 | 80.96 | -- | 59.35 | -- |
| ADMA Biologics Inc | 283.18m | -3.64m | 3.05bn | 624.00 | -- | 19.84 | 639.69 | 10.77 | -0.0204 | -0.0204 | 1.23 | 0.6632 | 0.8188 | 0.9923 | 7.44 | 453,808.40 | -1.05 | -24.80 | -1.21 | -28.00 | 40.13 | 17.40 | -1.29 | -51.31 | 1.86 | 2.19 | 0.4598 | -- | 67.59 | 72.34 | 57.15 | -- | 18.91 | -- |
| Twist Bioscience Corp | 277.49m | -192.14m | 3.38bn | 919.00 | -- | 6.03 | -- | 12.19 | -3.35 | -3.35 | 4.83 | 9.63 | 0.3565 | 4.87 | 7.04 | 301,943.40 | -24.68 | -30.50 | -27.12 | -33.84 | 38.29 | 36.02 | -69.24 | -113.33 | 5.06 | -- | 0.00 | -- | 20.41 | 57.33 | 6.08 | -- | 49.76 | -- |
| Prestige Consumer Healthcare Inc | 1.13bn | 209.34m | 3.51bn | 570.00 | 16.94 | 2.13 | 14.63 | 3.12 | 4.17 | 4.17 | 22.43 | 33.22 | 0.3373 | 3.33 | 6.55 | 1,974,311.00 | 6.28 | 3.69 | 6.55 | 3.84 | 55.49 | 56.79 | 18.60 | 12.19 | 2.02 | 5.10 | 0.4052 | 0.00 | -0.21 | 2.89 | 354.34 | -- | -1.84 | -- |
| Corcept Therapeutics Incorporated | 523.53m | 118.02m | 3.71bn | 352.00 | 33.30 | 6.76 | 31.14 | 7.08 | 1.07 | 1.07 | 4.74 | 5.27 | 0.822 | 1.12 | 11.13 | 1,487,298.00 | 18.53 | 21.17 | 21.50 | 23.85 | 98.54 | 98.52 | 22.54 | 27.23 | 5.10 | -- | 0.00 | 0.00 | 20.04 | 13.93 | 4.66 | 7.08 | -14.15 | -- |
| Perrigo Company PLC | 4.56bn | 700.00k | 3.83bn | 9.14k | 8,895.57 | 0.8175 | 10.86 | 0.8411 | 0.0032 | -0.0585 | 33.33 | 34.39 | 0.4219 | 2.54 | 5.78 | 498,457.30 | 0.0065 | -0.1148 | 0.0074 | -0.1315 | 35.65 | 35.28 | 0.0154 | -0.2985 | 1.08 | 1.26 | 0.4645 | -- | 4.58 | -0.3238 | 96.64 | -- | -5.95 | 7.52 |
| Axsome Therapeutics Inc | 251.02m | -296.38m | 4.11bn | 545.00 | -- | 28.51 | -- | 16.37 | -6.38 | -6.38 | 5.41 | 3.03 | 0.537 | 2.11 | 3.43 | 460,592.70 | -63.40 | -64.55 | -85.88 | -82.23 | 90.12 | -- | -118.07 | -227.05 | 3.09 | -55.54 | 0.556 | -- | 440.80 | -- | -27.84 | -- | 77.86 | -- |
| Apellis Pharmaceuticals Inc | 524.07m | -417.27m | 4.82bn | 702.00 | -- | 18.08 | -- | 9.21 | -3.46 | -3.46 | 4.33 | 2.20 | 0.5788 | 0.5747 | 3.50 | 746,538.40 | -46.09 | -73.88 | -57.28 | -90.03 | 86.47 | -- | -79.62 | -326.49 | 3.02 | -38.72 | 0.6087 | -- | 425.83 | -- | 18.94 | -- | -- | -- |
| BridgeBio Pharma Inc | 218.60m | -538.26m | 5.06bn | 550.00 | -- | -- | -- | 23.16 | -3.23 | -3.23 | 1.29 | -5.61 | 0.2964 | -- | -- | 397,449.10 | -74.13 | -72.44 | -90.19 | -89.72 | 98.91 | 94.41 | -250.09 | -1,225.66 | -- | -11.48 | 2.53 | -- | -88.02 | -- | -33.67 | -- | -40.94 | -- |
| Avidity Biosciences Inc | 10.87m | -228.68m | 5.11bn | 253.00 | -- | 5.54 | -- | 470.08 | -2.95 | -2.95 | 0.1408 | 8.69 | 0.0139 | -- | -- | 42,964.43 | -29.22 | -31.61 | -31.71 | -34.45 | -- | -- | -2,103.78 | -1,540.50 | -- | -- | 0.00 | -- | 3.64 | 90.71 | -21.97 | -- | 143.89 | -- |
